Related references
Note: Only part of the references are listed.Severity of COVID-19 in children with cancer: Report from the United Kingdom Paediatric Coronavirus Cancer Monitoring Project
Gerard C. Millen et al.
BRITISH JOURNAL OF CANCER (2021)
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study
Sheena Mukkada et al.
LANCET ONCOLOGY (2021)
Children and young people remain at low risk of COVID-19 mortality
Sunil S. Bhopal et al.
LANCET CHILD & ADOLESCENT HEALTH (2021)
Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study
Dylan Graetz et al.
LANCET CHILD & ADOLESCENT HEALTH (2021)
Testing at scale during the COVID-19 pandemic
Tim R. Mercer et al.
NATURE REVIEWS GENETICS (2021)
Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study
Souad Assaad et al.
BRITISH JOURNAL OF CANCER (2021)
Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London
Beth Russell et al.
BRITISH JOURNAL OF CANCER (2021)
Letter: Is the Stupp Protocol an Expensive and Unsustainable Standard of Care for Glioblastoma in Low- and Middle-Income Country Settings? A Call to Action!
Gideon Adegboyega et al.
NEUROSURGERY (2021)
Impact of the COVID-19 pandemic on paediatric patients with cancer in low-income, middle-income and high-income countries: protocol for a multicentre, international, observational cohort study
Noel Peter et al.
BMJ OPEN (2021)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Sustainable care for children with cancer: a Lancet Oncology Commission
Rifat Atun et al.
LANCET ONCOLOGY (2020)
Early impact of the COVID-19 pandemic on paediatric cancer care in Latin America Comment
Liliana Vasquez et al.
LANCET ONCOLOGY (2020)
A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries
Yazid Belkacemi et al.
EUROPEAN JOURNAL OF CANCER (2020)
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Lennard Y. W. Lee et al.
LANCET ONCOLOGY (2020)
Science and health for all children with cancer
Catherine G. Lam et al.
SCIENCE (2019)
The Lancet Commission on diagnostics: advancing equitable access to diagnostics
Michael L. Wilson et al.
LANCET (2019)
The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017
Lisa M. Force et al.
LANCET ONCOLOGY (2019)
Fighting childhood cancer with data
[Anonymous]
LANCET CHILD & ADOLESCENT HEALTH (2019)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?
Jacobus Adrianus Burgers et al.
ERJ OPEN RESEARCH (2018)
Estimates of Cancer Incidence in Ethiopia in 2015 Using Population-Based Registry Data
Solomon Tessema Memirie et al.
JOURNAL OF GLOBAL ONCOLOGY (2018)
30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study
Michael Wallington et al.
LANCET ONCOLOGY (2016)
Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines
Sumit Gupta et al.
LANCET ONCOLOGY (2016)
Mortality within 30 days following systemic anti-cancer therapy, a review of all cases over a 4 year period in a tertiary cancer centre
L. Khoja et al.
EUROPEAN JOURNAL OF CANCER (2015)
Global cancer surgery: delivering safe, affordable, and timely cancer surgery
Richard Sullivan et al.
LANCET ONCOLOGY (2015)
Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries
Kathy Pritchard-Jones et al.
LANCET ONCOLOGY (2013)
Paediatric cancer in low-income and middle-income countries
Ian Magrath et al.
LANCET ONCOLOGY (2013)
Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial
Birgitta Lannering et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
MECC Regional Initiative in Pediatric Palliative Care: Middle Eastern Course on Pain Management
Michael Silbermann et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2012)
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Yousif Matloub et al.
BLOOD (2011)
The answer is 17 years, what is the question: understanding time lags in translational research
Zoe Slote Morris et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2011)
Childhood cancer epidemiology in low-income countries
Scott C. Howard et al.
CANCER (2008)
Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study
Raul C. Ribeiro et al.
LANCET ONCOLOGY (2008)
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95
W Woessmann et al.
BLOOD (2005)